Medicus Sciences Acquisition Corp. (the “Company”) (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Charter”), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.18.
Apple Resumes Its Pursuit Of Thinness: After iPad Pro, Tim Cook’s Company Is Focusing On Making This Device ‘Significantly Skinnier’
approved by Benzinga's editorial team.Apple plans to launch a thinner iPhone 17 as part of its focus on thinness, following the success of the OLED iPad Pro. The company is also working on making the MacBook Pro and Apple Watch slimmer.
